Clinical trial
Comparative Study of Gemcitabine,Cisplatin and Radiation Versus Cisplatin and…
NCT00191100 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00191100 |
|---|---|
| Title | Comparative Study of Gemcitabine,Cisplatin and Radiation Versus Cisplatin and Radiation in Cancer of the Cervix |
| Official title | Phase 3 Randomized Comparison of Concurrent Gemcitabine, Cisplatin, and Radiation Followed by Adjuvant Gemcitabine and Cisplatin Versus Concurrent Cisplatin and Radiation in Cancer of the Cervix Stages IIB to IVA |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cancer of Cervix |
| Intervention type | Drug, Radiation |
| Interventions | Gemcitabine, Cisplatin, Brachytherapy, Pelvic radiation |
| Enrollment | 515 |
| Start date | May 1, 2002 |
| Primary completion | Apr 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | Sep 19, 2005 |
| Last update posted | Aug 11, 2009 |
| Countries | Argentina, Bosnia and Herzegovina, India, Mexico, Pakistan, Peru, Thailand |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: